In today’s recent session, 1.02 million shares of the Sunshine Biopharma Inc (NASDAQ:SBFM) have been traded, and its beta is -1.02. Most recently the company’s share price was $0.90, and it changed around $0.0 or 0.06% from the last close, which brings the market valuation of the company to $0.89M. SBFM at last check was trading at a discount to its 52-week high of $72.00, offering almost -7900.0% off that amount. The share price’s 52-week low was $0.75, which indicates that the recent value has risen by an impressive 16.67% since then. We note from Sunshine Biopharma Inc’s average daily trading volume that its 3-month average coming to 2.72 million.
Sunshine Biopharma Inc (NASDAQ:SBFM) trade information
Instantly SBFM has been showing a green trend so far today with a performance of 0.06% on intraday trading today. The performance over the last five days has remained in the red territory. The company’s shares are currently down -96.68% year-to-date, but still down -9.09% over the last five days. On the other hand, Sunshine Biopharma Inc (NASDAQ:SBFM) is -86.76% down in the 30-day period.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Sunshine Biopharma Inc (SBFM) estimates and forecasts
The year-over-year growth rate is expected to be 84.30%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of $7 million in revenue for the current quarter. 1 analysts expect Sunshine Biopharma Inc to make $9 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were -$.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 73.50%.
